Guillermo Ruiz Palacios
Biographic Data
| ID | 9073495 |
|---|---|
| NAME | Guillermo Ruiz Palacios |
| GIVEN NAMES | Guillermo Ruiz |
| FAMILY NAME | Palacios |
| SIGNATURE | PALACIOS G R |
| AFFILIATIONS | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán |
| ORCID | 0000-0003-3708-9654 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Challenges of conducting an international observational study to assess immunogenicity of multiple Covid-19 vaccines
The International Study on COVID-19 Vaccines to Assess Immunogenicity, Reactogenicity, and Efficacy is an observational study to assess the immunogenicity of COVID-19 vaccines used in Democratic Republic of Congo, Guinea, Indonesia, Liberia, Mali, Mexico, and Mongolia. The study, which has enrolled 5,401 adults, is prospectively following participants for approximately two years. This study is important as it has enrolled participants from resour…
International clinical research networks – a collaborative approach for pandemic preparedness and response
In the last 100 years, the world has experienced four influenza pandemics, with an occurrence every 15-30 years resulting in an annual probability of 3% to 7% [1]. More recently, other pathogens including SARS, MERS, and the recent SARS CoV-2, have stressed the need to improve pandemic preparedness and response capabilities. Developing strategies to promote [...]
Remdesivir for the Treatment of Covid-19 — Final Report
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (2…
No prominent works on this page.
Remdesivir for the Treatment of Covid-19 — Final Report
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be efficacious. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. Patients were randomly assigned to receive either remdesivir (2…
Challenges of conducting an international observational study to assess immunogenicity of multiple Covid-19 vaccines
The International Study on COVID-19 Vaccines to Assess Immunogenicity, Reactogenicity, and Efficacy is an observational study to assess the immunogenicity of COVID-19 vaccines used in Democratic Republic of Congo, Guinea, Indonesia, Liberia, Mali, Mexico, and Mongolia. The study, which has enrolled 5,401 adults, is prospectively following participants for approximately two years. This study is important as it has enrolled participants from resour…
International clinical research networks – a collaborative approach for pandemic preparedness and response
In the last 100 years, the world has experienced four influenza pandemics, with an occurrence every 15-30 years resulting in an annual probability of 3% to 7% [1]. More recently, other pathogens including SARS, MERS, and the recent SARS CoV-2, have stressed the need to improve pandemic preparedness and response capabilities. Developing strategies to promote [...]
Medicine (3 works) · 2019-20 coronavirus outbreak (2 works) · COVID-19 Clinical Research Studies (2 works) · Disease (2 works) · Outbreak (2 works) · Pandemic (2 works) · Political science (2 works) · Preparedness (2 works) · SARS-CoV-2 and COVID-19 Research (2 works) · Business (1 work)